Clinical Trials Directory

Trials / Completed

CompletedNCT02464462

The Role of Vitamin D3 and Calcium Supplementation in Attenuating T2DM Severity

The Role of Vitamin D and Calcium Supplementation in the Pathogenesis of Type 2 Diabetes Mellitus

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
11 (actual)
Sponsor
York University · Academic / Other
Sex
Female
Age
40 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the effect of vitamin D3 and calcium supplementation in attenuating type 2 diabetes mellitus outcomes in ethnic diverse, diabetic patiens.

Detailed description

Subjects of this study received a total of 1800 IU vitamin D3 and 720 mg of calcium per day for 3 years. The study was conducted in Toronto, Ontario, Canada.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTvitamin D3 and calcium1800 IU vitamin D3 plus 720 mg Calcium
OTHERPlaceboRice powder pills

Timeline

Start date
2010-05-01
Primary completion
2013-08-01
Completion
2013-12-01
First posted
2015-06-08
Last updated
2015-06-08

Source: ClinicalTrials.gov record NCT02464462. Inclusion in this directory is not an endorsement.

The Role of Vitamin D3 and Calcium Supplementation in Attenuating T2DM Severity (NCT02464462) · Clinical Trials Directory